KRAS and cancer: However, based on our molecular mechanism that explains K-Ras targeting, we included in our cellular analysis KRAS mutant, HIF-1α high, and/or Gal3 high cancer types, such as pancreatic and lung adenocarcinoma (Figure S4A,B).